REG OF NITRIC OXIDE PRODUCT IN THE HEPATIC CIRCULATION
REG OF NITRIC OXIDE PRODUCT IN THE HEPATIC CIRCULATION
批准号:
2904993
负责人:
VIJAY H. SHAH
金额:
$12.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2003-06-30
中文摘要
一氧化氮(NO)在肝脏的调节中起重要作用,
血管舒张张力。 肝内血管收缩有助于
肝硬化门静脉压力升高的发展。 的
这种血管收缩的来源似乎是一种改变,
窦内皮细胞(SEC)是一种独特微血管细胞,
在肝窦内的阻力血管上排列,表达NO
合成酶(NOS)III. 剪应力是一种生理生物力学力
已经发现其调节通过血管的局部血流,
调节内皮细胞产生血管扩张物质,
初步研究表明,剪切应力激活了
酪氨酸磷酸化级联反应,并另外引起亚细胞
NO合酶(NOS)III的再分布,这两个事件是新的
NOS的调节机制III. 这些长期目标
研究的目的是阐明NO产生的调控机制
在肝脏微循环中的剪切应力,并检查它们如何
可能有助于肝硬化中所见的血流动力学改变。
了解调节门静脉压力的机制至关重要,
门静脉高压的发展是最重要的
决定哪些肝硬化患者会发展的因素
并发症 定义调节一氧化氮的机制
在SEC中的产生可能导致治疗选择,
可能是可调节的或基因调节的,
肝硬化和门脉高压
英文摘要
Nitric oxide (NO) plays an important role in the regulation of hepatic
vasodilator tone. Intrahepatic vasoconstriction contributes to the
development of an increase in portal pressure in hepatic cirrhosis. The
source of this vasoconstriction appears to be an alteration in the
sinusoidal endothelial cell (SEC), a unique microvascular cell which
lines the resistance vessels in the hepatic sinusoids and expresses NO
synthase (NOS) III. Shear stress is a physiologic biomechanical force
which has been found to modulate regional blood flow through the
regulation of endothelial cell production of vasodilator substances such
as NO. Preliminary studies suggest that shear stress activates a
tyrosine phosphorylation cascade and additionally causes a subcellular
redistribution of NO synthase (NOS) III, two events which are novel
mechanisms of regulation of NOS III. The long term objective of these
studies is to elucidate the mechanisms of regulation of NO production
in the hepatic microcirculation by shear stress and to examine how they
may contribute to the hemodynamic alterations seen in cirrhosis.
Understanding the mechanisms that regulate portal pressure is vital as
the development of portal hypertension is the single most important
factor that determines which patients with cirrhosis will develop
complications. Defining the mechanisms that regulate nitric oxide
production in SEC may lead to therapeutic options whereby NO activity
may be pharmacologically or genetically modulated and benefit patients
with cirrhosis and portal hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of Liver Fibrosis
-
批准号:10407227
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2022
-
负责人:VIJAY H. SHAH
-
依托单位:
Molecular Mechanisms of Liver Fibrosis
-
批准号:10612941
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2022
-
负责人:VIJAY H. SHAH
-
依托单位:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
-
批准号:10487453
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2021
-
负责人:VIJAY H. SHAH
-
依托单位:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
-
批准号:10310667
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2021
-
负责人:VIJAY H. SHAH
-
依托单位:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
-
批准号:10700154
-
项目类别:
-
资助金额:$21.04万
-
财政年份:2021
-
负责人:VIJAY H. SHAH
-
依托单位:
Assessment of Alcoholic Hepatitis with Multiparametric Magnetic Resonance Elastography
-
批准号:10459414
-
项目类别:
-
资助金额:$38.17万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Randomized Placebo Controlled Pilot Trial to determine the efficacy of an IL22 agonist (F-652) in patients with Alcoholic Hepatitis
-
批准号:10202402
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Assessment of Alcoholic Hepatitis with Multiparametric Magnetic Resonance Elastography
-
批准号:10205237
-
项目类别:
-
资助金额:$38.17万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Randomized Placebo Controlled Pilot Trial to determine the efficacy of an IL22 agonist (F-652) in patients with Alcoholic Hepatitis
-
批准号:9791141
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Randomized Placebo Controlled Pilot Trial to determine the efficacy of an IL22 agonist (F-652) in patients with Alcoholic Hepatitis
-
批准号:10449219
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Assessment of Alcoholic Hepatitis with Multiparametric Magnetic Resonance Elastography
-
批准号:9791139
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Targeting matrix stiffness in lung and liver fibrosis
-
批准号:9165025
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2016
-
负责人:VIJAY H. SHAH
-
依托单位:
Targeting matrix stiffness in lung and liver fibrosis
-
批准号:9332421
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2016
-
负责人:VIJAY H. SHAH
-
依托单位:
TREAT-Mayo
-
批准号:8706608
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2013
-
负责人:VIJAY H. SHAH
-
依托单位:
TREAT-Mayo
-
批准号:8693889
-
项目类别:
-
资助金额:$58.93万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
TREAT-Mayo
-
批准号:9524876
-
项目类别:
-
资助金额:$62.5万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
Molecular Mechanisms of Liver Fibrosis
-
批准号:10152468
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
Molecular Mechanisms of Liver Fibrosis
-
批准号:8466909
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
TREAT-Mayo
-
批准号:8546293
-
项目类别:
-
资助金额:$52.2万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
Molecular Mechanisms of Liver Fibrosis
-
批准号:9056498
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
海外基金